# Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)

> **NCT03879772** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 679 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Mometasone furoate nasal spray
- **DRUG:** Beclomethasone dipropionate nasal spray
- **DRUG:** Placebo nasal spray
- **DRUG:** Chlorpheniramine maleate syrup

## Key facts

- **NCT ID:** NCT03879772
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-03-12
- **Primary completion:** 1996-07-01
- **Final completion:** 1996-07-01
- **Target enrollment:** 679 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879772, "Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03879772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*